CRCM LP 对 ANAB 的持仓历史
ANAPTYSBIO INC COM · 医疗保健
CRCM LP 在 Q3 2026 的 13F 申报中披露持有 ANAB(ANAPTYSBIO INC COM)181,114 股,市值约 US$9.1M,约占其申报组合的 5.15%,在其申报持仓中市值排名第 4 位。 CRCM LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-12 · 来源: SEC EDGAR Form 13F-HR
CRCM LP 对 ANAB 的持仓演变
CRCM LP 于 Q3 2026 首次披露 ANAB 持仓:181,114 股(约 US$9.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 181.11K | $9.10M | 新进 |
关于 ANAB 与 13F 数据
ANAB(ANAPTYSBIO INC COM)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 ANAB,申报仓位最大的包括:EcoR1 Capital, LLC (US$531.9M), TANG CAPITAL MANAGEMENT LLC (US$89.8M), Affinity Asset Advisors, LLC (US$55.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANAB 的基金
- EcoR1 Capital, LLC 7.88M 股 · $531.91M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.33M 股 · $89.83M · Q2 2026
- Affinity Asset Advisors, LLC 826.11K 股 · $55.76M · Q2 2026
- 683 Capital Management, LLC 660.00K 股 · $44.55M · Q2 2026
- Sanofi 821.92K 股 · $41.31M · Q3 2026
- Palo Alto Investors LP 603.49K 股 · $40.74M · Q2 2026
- First Light Asset Management, LLC 582.00K 股 · $39.29M · Q2 2026
- APIS CAPITAL ADVISORS, LLC 497.00K 股 · $33.55M · Q2 2026
- Sofinnova Investments, Inc. 493.54K 股 · $33.31M · Q2 2026
- Coppell Advisory Solutions LLC 3.64K 股 · $16.58M · Q2 2026
- Greenhaven Road Investment Management, L.P. 171.06K 股 · $11.55M · Q2 2026
更多关于 CRCM LP
常见问题
How long has CRCM LP held ANAB?
CRCM LP has disclosed ANAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is CRCM LP's current position in ANAB?
As of Q3 2026, CRCM LP holds 181.11K shares of ANAB (ANAPTYSBIO INC COM), valued at $9.10M, representing 5.15% of its reported portfolio and ranking #4.
Has CRCM LP been buying or selling ANAB?
In the latest 13F filing (Q3 2026), CRCM LP newly opened its position in ANAB.
Which other funds hold ANAB?
Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.